These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
188 related articles for article (PubMed ID: 17379312)
1. Defective B cell ontogeny and immune response in human complement receptor 2 (CR2, CD21) transgenic mice is partially recovered in the absence of C3. Twohig J; Kulik L; Haluszczak C; Reuter J; Rossbach A; Bull M; Holers VM; Marchbank KJ Mol Immunol; 2007 Jul; 44(13):3434-44. PubMed ID: 17379312 [TBL] [Abstract][Full Text] [Related]
2. Expression of human complement receptor 2 (CR2, CD21) in Cr2-/- mice restores humoral immune function. Marchbank KJ; Watson CC; Ritsema DF; Holers VM J Immunol; 2000 Sep; 165(5):2354-61. PubMed ID: 10946257 [TBL] [Abstract][Full Text] [Related]
3. Human complement receptor type 2 (CR2/CD21) transgenic mice provide an in vivo model to study immunoregulatory effects of receptor antagonists. Kulik L; Chen K; Huber BT; Holers VM Mol Immunol; 2011 Mar; 48(6-7):883-94. PubMed ID: 21269698 [TBL] [Abstract][Full Text] [Related]
4. Expression of human complement receptor type 2 (CD21) in mice during early B cell development results in a reduction in mature B cells and hypogammaglobulinemia. Marchbank KJ; Kulik L; Gipson MG; Morgan BP; Holers VM J Immunol; 2002 Oct; 169(7):3526-35. PubMed ID: 12244142 [TBL] [Abstract][Full Text] [Related]
5. B cells from mice prematurely expressing human complement receptor type 2 are unresponsive to T-dependent antigens. Birrell L; Kulik L; Morgan BP; Holers VM; Marchbank KJ J Immunol; 2005 Jun; 174(11):6974-82. PubMed ID: 15905540 [TBL] [Abstract][Full Text] [Related]
6. Defective B cell ontogeny and humoral immune response in mice prematurely expressing human complement receptor 2 (CR2, CD21) is similar to that seen in aging wild type mice. Twohig JP; Pappworth IY; Sivasankar B; Kulik L; Bull M; Holers VM; Wang EC; Marchbank KJ Mol Immunol; 2009 Jun; 46(10):2002-13. PubMed ID: 19359041 [TBL] [Abstract][Full Text] [Related]
7. Increased B cell deletion and significantly reduced auto-antibody titre due to premature expression of human complement receptor 2 (CR2, CD21). Pappworth IY; Kulik L; Haluszczak C; Reuter JW; Holers VM; Marchbank KJ Mol Immunol; 2009 Mar; 46(6):1042-9. PubMed ID: 19187965 [TBL] [Abstract][Full Text] [Related]
8. Intrinsic B cell hypo-responsiveness in mice prematurely expressing human CR2/CD21 during B cell development. Kulik L; Marchbank KJ; Lyubchenko T; Kuhn KA; Liubchenko GA; Haluszczak C; Gipson MG; Boackle SA; Holers VM Eur J Immunol; 2007 Mar; 37(3):623-33. PubMed ID: 17301948 [TBL] [Abstract][Full Text] [Related]
9. CD19 can regulate B lymphocyte signal transduction independent of complement activation. Hasegawa M; Fujimoto M; Poe JC; Steeber DA; Tedder TF J Immunol; 2001 Sep; 167(6):3190-200. PubMed ID: 11544305 [TBL] [Abstract][Full Text] [Related]
10. Impaired antibody response to group B streptococcal type III capsular polysaccharide in C3- and complement receptor 2-deficient mice. Pozdnyakova O; Guttormsen HK; Lalani FN; Carroll MC; Kasper DL J Immunol; 2003 Jan; 170(1):84-90. PubMed ID: 12496386 [TBL] [Abstract][Full Text] [Related]
11. Evidence for an important interaction between a complement-derived CD21 ligand on follicular dendritic cells and CD21 on B cells in the initiation of IgG responses. Qin D; Wu J; Carroll MC; Burton GF; Szakal AK; Tew JG J Immunol; 1998 Nov; 161(9):4549-54. PubMed ID: 9794381 [TBL] [Abstract][Full Text] [Related]
12. [Role of the complement C3 protein in the control of the specific immune response]. Villiers CL; Villiers MB; Marche PN Ann Biol Clin (Paris); 1999; 57(2):127-35. PubMed ID: 10210739 [TBL] [Abstract][Full Text] [Related]
13. Mouse complement receptors type 1 (CR1;CD35) and type 2 (CR2;CD21): expression on normal B cell subpopulations and decreased levels during the development of autoimmunity in MRL/lpr mice. Takahashi K; Kozono Y; Waldschmidt TJ; Berthiaume D; Quigg RJ; Baron A; Holers VM J Immunol; 1997 Aug; 159(3):1557-69. PubMed ID: 9233655 [TBL] [Abstract][Full Text] [Related]
14. Cross-linking CD21/CD35 or CD19 increases both B7-1 and B7-2 expression on murine splenic B cells. Kozono Y; Abe R; Kozono H; Kelly RG; Azuma T; Holers VM J Immunol; 1998 Feb; 160(4):1565-72. PubMed ID: 9469411 [TBL] [Abstract][Full Text] [Related]
15. Uncoupling CD21 and CD19 of the B-cell coreceptor. Barrington RA; Schneider TJ; Pitcher LA; Mempel TR; Ma M; Barteneva NS; Carroll MC Proc Natl Acad Sci U S A; 2009 Aug; 106(34):14490-5. PubMed ID: 19706534 [TBL] [Abstract][Full Text] [Related]
16. A role for CD21/CD35 and CD19 in responses to acute septic peritonitis: a potential mechanism for mast cell activation. Gommerman JL; Oh DY; Zhou X; Tedder TF; Maurer M; Galli SJ; Carroll MC J Immunol; 2000 Dec; 165(12):6915-21. PubMed ID: 11120817 [TBL] [Abstract][Full Text] [Related]
17. An intronic silencer regulates B lymphocyte cell- and stage-specific expression of the human complement receptor type 2 (CR2, CD21) gene. Makar KW; Pham CT; Dehoff MH; O'Connor SM; Jacobi SM; Holers VM J Immunol; 1998 Feb; 160(3):1268-78. PubMed ID: 9570543 [TBL] [Abstract][Full Text] [Related]
19. Mice expressing human CR1/CD35 have an enhanced humoral immune response to T-dependent antigens but fail to correct the effect of premature human CR2 expression. Pappworth IY; Hayes C; Dimmick J; Morgan BP; Holers VM; Marchbank KJ Immunobiology; 2012 Feb; 217(2):147-57. PubMed ID: 21783272 [TBL] [Abstract][Full Text] [Related]
20. EBV binds to lymphocytes of transgenic mice that express the human CR2 gene. Kearns-Jonker M; Monell-Torrens E; Abbasi F; Holers VM; Notkins AL; Sigounas G Virus Res; 1997 Jul; 50(1):85-94. PubMed ID: 9255938 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]